Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups
Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
06/2003
06/24/2003US6583134 Aza- indolyl derivatives for treating obesity
06/24/2003US6582879 Reactive photo acid-generating agent and heat-resistant photoresist composition with polyamide precursor
06/24/2003US6582351 Benzimidazole heterocyclic compounds having pharmacological activities, and their use as a medicament for treatment or prevention of diseases mediated by cGMP-PDE
06/24/2003CA2066094C Fused heterocyclic compounds, their production and use
06/19/2003WO2003050121A1 Thioether substituted imidazoquinolines
06/19/2003WO2003050120A1 Pyrazolo-pyridine derivatives as antiherpes agents
06/19/2003WO2003050119A2 Urea substituted imidazopyridines
06/19/2003WO2003050118A1 Amide substituted imidazopyridines
06/19/2003WO2003050117A1 Sulfonamido substituted imidazopyridines
06/19/2003WO2003050099A1 Phenylalkynes
06/19/2003WO2003050098A1 2-substituted thiazolidinone and oxazolidinone derivatives for the inhibition of phosphatases and the treatment of cancer
06/19/2003WO2003049741A1 Ureas of 2-aminobenzothiazoles as adenosine modulators
06/19/2003WO2003049739A1 Pyrimidine-based compounds useful as gsk-3 inhibitors
06/19/2003WO2003049702A2 Vanilloid receptor ligands and their use in treatments
06/19/2003WO2003049688A2 Bis hydrochloride monohydrate salt of rsv fusion inhibitor
06/19/2003WO2003049681A2 Synthesis of 4,5-dihydro-pyrazolo [3,4-c] pyrid-2-ones
06/19/2003WO2000077000A9 New bispidine compounds useful in the treatment of cardiac arrhythmias
06/19/2003US20030114674 2-Hydroxy-mutilin carbamate derivatives for antibacterial use
06/19/2003US20030114671 Corticotropin releasing factor antagonists
06/19/2003US20030114666 Antibacterial agents
06/19/2003US20030114508 Fused imidazolium derivatives
06/19/2003US20030114489 Asthma therapy; antiallergens; antiinflammatory agents
06/19/2003US20030114485 Killing drug resistant cancer cells; controlling cell differentiation
06/19/2003US20030114481 Respiratory syncytial virus
06/19/2003US20030114478 Asthma therapy; antiinflammatory agents
06/19/2003US20030114468 Psychological disorders
06/19/2003US20030114461 Cyclization 1,4-diazabicyclo(3,2,2)nonane with isooxazole compound
06/19/2003US20030114458 Antibacterial agents
06/19/2003US20030114457 2- [5- (5-carbamimidoyl-1H-heteroaryl)-6-hydroxybiphenyl-3-yl]-succinic acid derivatives as factor viia inhibitors
06/19/2003US20030114449 Saccharin derivatives as orally active elastase inhibitors
06/19/2003US20030114445 Bactericides
06/19/2003US20030114443 Viricides, Aids therapy
06/19/2003US20030114432 Antiinflammatory agents; rheumatic diseases; anticancer agents
06/19/2003US20030114422 Thrombosis, brain disorders, cardiovascular disorders, Alzheimer's disease, Huntington diseases
06/19/2003US20030114420 Anticancer agents, autoimmunine diseases, congestive heart failure, skin disorders, antiinflammatory agents
06/19/2003US20030113755 Fluorescent nucleotides and labeling methods using the same
06/19/2003US20030111649 Chemiluminescent composition for emitting red light
06/19/2003US20030111641 Yellow pigment mixture comprising pigment violet 19 and a polyamide
06/19/2003CA2469893A1 Phenylalkynes
06/19/2003CA2469596A1 Ureas of 2-aminobenzothiazoles as adenosine modulators
06/19/2003CA2469342A1 2-substituted thiazolidinone and oxazolidinone derivatives for the inhibition of phosphatases and the treatment of cancer
06/19/2003CA2469316A1 Pyrimidine-based compounds useful as gsk-3 inhibitors
06/19/2003CA2468659A1 Urea substituted imidazopyridines
06/19/2003CA2468544A1 Vanilloid receptor ligands
06/19/2003CA2468174A1 Amide substituted imidazopyridines
06/19/2003CA2468164A1 Sulfonamido substituted imidazopyridines
06/18/2003EP1319661A1 Process for producing tricyclic fused heterocyclic derivative
06/18/2003EP1319007A1 Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
06/18/2003EP1319006A1 Tetrahydrocarbazoles, a process for the preparation of those compounds, and the use thereof
06/18/2003EP1319002A1 Alpha v integrin receptor antagonists
06/18/2003EP1319001A1 Pyrazolopyridines and pyrazolopyridazines as antidiabetics
06/18/2003EP1318997A1 Pyrazole compounds useful as protein kinase inhibitors
06/18/2003EP1318995A2 Pyridinone and pyridinethione derivatives having hiv inhibiting properties
06/18/2003EP1318980A2 Hydroxamate derivatives useful as deacetylase inhibitors
06/18/2003EP1318835A1 Use of imidazoquinolinamines as adjuvants in dna vaccination
06/18/2003EP1318814A2 Triazole compounds useful as protein kinase inhibitors
06/18/2003EP1318813A1 Stable pergolide mesylate and process for making same
06/18/2003EP1318812A1 Methods for delaying recurrence of herpes virus symptoms
06/18/2003EP1255757B1 Amino acid derivatives and use thereof as nep, ace and ece inhibitors
06/18/2003EP1015451B1 Tetrahydro gamma-carbolines
06/18/2003EP0815859B1 Intimal thickening inhibitors
06/18/2003CN1425014A Triazatrinaphthyrins and use thereof
06/18/2003CN1425008A 3-aminoquinazolin-2, 4-dione antibacterial agents
06/18/2003CN1111533C Preparation of matrine oxide
06/18/2003CN1111532C Process for preparing sophocarpine
06/18/2003CN1111531C Process for preparing 6-0-monoesters of castanospermine
06/18/2003CN1111529C Piperazino derivatives as neurokinin antagonists
06/17/2003US6579894 Bactericides, fungicides
06/17/2003US6579884 Gastrointestinal inflammatory diseases, antisecretory; infection by Helicobacter pylori of human gastric mucosa; Substituted imidazo(1,2-a)pyridines
06/17/2003US6579879 For therapy of diabetic neuropathy, diabetic retinopathy, diabetic nephropathy, diabetic cardiomyopathy, diabetic microangiopathy and diabetic macroangiopathy in mammals
06/17/2003US6579876 Imidazo(4,5-d)pyridazines
06/17/2003US6579867 Azepin-2-one derivatives useful for treating Alzheimer's disease
06/17/2003US6579863 Nitrosated and nitrosylated compounds and compositions and their use for treating respiratory disorders
06/17/2003US6579326 For dyeing hair
06/12/2003WO2003048163A1 [1,2,4]-TRIAZOLE BICYCLIC ADENOSINE A2a RECEPTOR ANTAGONISTS
06/12/2003WO2003048160A1 Ring fused pyrazole derivatives
06/12/2003WO2003048158A1 Glycinamides as factor xa inhibitors
06/12/2003WO2003048154A1 4-(piperidyl- and pyrrolidyl-alkyl-ureido) -quinolines as urotensin ii receptor antagonists
06/12/2003WO2003048132A1 Imidazopyridines, pyrimidines and triazines for enhancing cognition as gaba-a alpha 5 receptor subtype ligands
06/12/2003WO2003048127A1 Aromatic heterocyclic non-covalent inhibitors of urokinase and blood vessel formation
06/12/2003WO2003048123A1 Substituted 2-amino-cycloalkanecarboxamides and their use as cysteine protease inhibitors
06/12/2003WO2003048081A2 Glycinamides as factor xa inhibitors
06/12/2003WO2003047577A2 Pharmaceutical compositions comprising dihydropyridinone compounds and an immunoregulatory or an antiinflammatory agent and their uses
06/12/2003WO2003047520A2 SUBSTITUTED AMINO METHYL FACTOR Xa INHIBITORS
06/12/2003WO2003047505A2 Topoisomerase poison agents
06/12/2003WO2002047679A3 Nonpeptide agonists and antagonists of vasopressin receptors
06/12/2003WO2002017712A3 Disubstituted benzenes as insecticides
06/12/2003WO2002009683A9 Aldosterone blocker therapy to prevent or treat inflammation-related disorders
06/12/2003US20030109707 Reacting an imidazolo(1,2)pyridine with aromatic amide
06/12/2003US20030109705 Novel cyanoenamines useful as ligands for modulating gene expression in plants or animals
06/12/2003US20030109550 Substituted indazole compounds for the treatment of inflammation
06/12/2003US20030109541 3-Phenyl-3,7-diazabicyclo[3.3.1] nonane compounds, process for preparing them, pharmaceutical compositions containing them and use thereof to inhibit cardiac arrhythmia
06/12/2003US20030109539 Treating a condition selected from the group consisting of anxiety, depression, substance abuse, neuropathic pain, acute pain, migraine, asthma, cough and improved cognition, in a subject in need thereof comprising administering a compound
06/12/2003US20030109530 Diabetes, insulin resistance, dyslipidemia, obesity, high blood pressure, atherosclerosis, retinopathies and neurodegenerative disorders; synthesis by reacting a biguanide with an aldehyde, semiacetal or acetal in presence of acid catalyst
06/12/2003US20030106463 Use to provide transparent perylene pigments having excellent application and color properties; mixture with the pigment and rosin
06/12/2003CA2468927A1 Ring fused pyrazole derivatives
06/12/2003CA2468893A1 Imidazopyridines, pyrimidines and triazines for enhancing cognition as gaba-a alpha 5 receptor subtype ligands
06/12/2003CA2467435A1 Substituted 2-amino-cycloalkanecarboxamides and their use as cysteine protease inhibitors
06/11/2003EP1317455A1 Process for preparing a substituted imidazopyridine compound
06/11/2003EP1317454A2 Caspase inhibitors and uses thereof
1 ... 419 420 421 422 423 424 425 426 427 428 429 430 431 432 433 434 435 436 437 438 439 ... 646